BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32141088)

  • 1. Termination of acute stress response by the endocannabinoid system is regulated through lysine-specific demethylase 1-mediated transcriptional repression of 2-AG hydrolases ABHD6 and MAGL.
    Longaretti A; Forastieri C; Gabaglio M; Rubino T; Battaglioli E; Rusconi F
    J Neurochem; 2020 Oct; 155(1):98-110. PubMed ID: 32141088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum.
    Zhong P; Pan B; Gao XP; Blankman JL; Cravatt BF; Liu QS
    J Physiol; 2011 Oct; 589(Pt 20):4847-55. PubMed ID: 21911610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
    Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
    J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid-Epigenetic Cross-Talk: A Bridge toward Stress Coping.
    Rusconi F; Rubino T; Battaglioli E
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors.
    Savinainen JR; Saario SM; Laitinen JT
    Acta Physiol (Oxf); 2012 Feb; 204(2):267-76. PubMed ID: 21418147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum.
    Chen Y; Liu X; Vickstrom CR; Liu MJ; Zhao L; Viader A; Cravatt BF; Liu QS
    eNeuro; 2016; 3(3):. PubMed ID: 27182552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice.
    Pan B; Wang W; Zhong P; Blankman JL; Cravatt BF; Liu QS
    J Neurosci; 2011 Sep; 31(38):13420-30. PubMed ID: 21940435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model.
    Miller S; Leishman E; Hu SS; Elghouche A; Daily L; Murataeva N; Bradshaw H; Straiker A
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3287-96. PubMed ID: 27333182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.
    Muldoon PP; Akinola LS; Schlosburg JE; Lichtman AH; Sim-Selley LJ; Mahadevan A; Cravatt BF; Damaj MI
    Neuropharmacology; 2020 Oct; 176():108170. PubMed ID: 32479813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endocannabinoid 2-arachidonoylglycerol and dual ABHD6/MAGL enzyme inhibitors display neuroprotective and anti-inflammatory actions in the in vivo retinal model of AMPA excitotoxicity.
    Kokona D; Spyridakos D; Tzatzarakis M; Papadogkonaki S; Filidou E; Arvanitidis KI; Kolios G; Lamani M; Makriyannis A; Malamas MS; Thermos K
    Neuropharmacology; 2021 Mar; 185():108450. PubMed ID: 33450278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain.
    Leishman E; Cornett B; Spork K; Straiker A; Mackie K; Bradshaw HB
    Pharmacol Res; 2016 Aug; 110():159-172. PubMed ID: 27109320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation.
    Sumislawski JJ; Ramikie TS; Patel S
    Neuropsychopharmacology; 2011 Dec; 36(13):2750-61. PubMed ID: 21849983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABHD6 Controls Amphetamine-Stimulated Hyperlocomotion: Involvement of CB
    Deng L; Viray K; Singh S; Cravatt B; Stella N
    Cannabis Cannabinoid Res; 2022 Apr; 7(2):188-198. PubMed ID: 34705543
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination.
    Manterola A; Bernal-Chico A; Cipriani R; Canedo-Antelo M; Moreno-García Á; Martín-Fontecha M; Pérez-Cerdá F; Sánchez-Gómez MV; Ortega-Gutiérrez S; Brown JM; Hsu KL; Cravatt B; Matute C; Mato S
    Biochem Pharmacol; 2018 Nov; 157():189-201. PubMed ID: 30075103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.
    Szekeres M; Nádasy GL; Turu G; Soltész-Katona E; Benyó Z; Offermanns S; Ruisanchez É; Szabó E; Takáts Z; Bátkai S; Tóth ZE; Hunyady L
    Mol Cell Endocrinol; 2015 Mar; 403():46-56. PubMed ID: 25595485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors.
    Marrs WR; Blankman JL; Horne EA; Thomazeau A; Lin YH; Coy J; Bodor AL; Muccioli GG; Hu SS; Woodruff G; Fung S; Lafourcade M; Alexander JP; Long JZ; Li W; Xu C; Möller T; Mackie K; Manzoni OJ; Cravatt BF; Stella N
    Nat Neurosci; 2010 Aug; 13(8):951-7. PubMed ID: 20657592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
    Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
    J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system.
    Chanda PK; Gao Y; Mark L; Btesh J; Strassle BW; Lu P; Piesla MJ; Zhang MY; Bingham B; Uveges A; Kowal D; Garbe D; Kouranova EV; Ring RH; Bates B; Pangalos MN; Kennedy JD; Whiteside GT; Samad TA
    Mol Pharmacol; 2010 Dec; 78(6):996-1003. PubMed ID: 20855465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats.
    Rivera P; Luque-Rojas MJ; Pastor A; Blanco E; Pavón FJ; Serrano A; Crespillo A; Vida M; Grondona JM; Cifuentes M; Bermúdez-Silva FJ; de la Torre R; de Fonseca FR; Suárez J
    Eur J Neurosci; 2013 Jan; 37(1):105-17. PubMed ID: 23033907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.